Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.55 |
| ▸ | ANPEP | P15144 | 3/20 | 0.53 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29395342 | 1.00 | IDO1 (0.55) | IDO1ANPEPPDPK1PLAU | |
| SCHEMBL42780 | 1.00 | IDO1 (0.55) | IDO1ANPEPPDPK1PLAU | |
| SCHEMBL28840240 | 1.00 | IDO1 (0.55) | IDO1ANPEPPDPK1PLAU | |
| SCHEMBL29858363 | 1.00 | IDO1 (0.55) | IDO1ANPEPPDPK1PLAU | |
| SCHEMBL12787610 | 1.00 | IDO1 (0.55) | IDO1ANPEPPDPK1PLAU | |
| SCHEMBL42279 | 1.00 | IDO1 (0.55) | IDO1ANPEPPDPK1PLAU | |
| Hydrochloric Acid SCHEMBL1948638 | 0.98 | IDO1 (0.57) | IDO1ANPEPPDPK1 | |
| Hydrochloric Acid SCHEMBL29676818 | 0.98 | IDO1 (0.57) | IDO1ANPEPPDPK1 | |
| Hydrochloric Acid SCHEMBL29397932 | 0.98 | IDO1 (0.57) | IDO1ANPEPPDPK1 | |
| Hydrochloric Acid SCHEMBL2033301 | 0.98 | IDO1 (0.57) | IDO1ANPEPPDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2660 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081258-A | Imine reductase mutant and application thereof in catalytic synthesis of chiral 1-aminoindane derivative | — | 2026-05-26 | — | — | CN | claimed |
| CN-119707698-A | Process method for synthesizing (S) - (+) -1-aminoindene | 大连双硼医药化工有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-114380751-B | Indanamine derivatives, preparation method and application thereof | 上海辉启生物医药科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-116396189-B | Preparation method of (S) - (+) -1-indanyl isocyanate | 无锡科华生物科技有限公司 | 2024-11-05 | — | — | CN | claimed |
| US-20240199542-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-06-20 | — | — | US | claimed |
| CN-113045456-B | Novel rasagiline impurity compound and preparation method and application thereof | 上海奥博生物医药股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117946394-A | Maleimide resin with low dielectric and high toughness indane condensation configuration, and preparation method and application thereof | 四川东材科技集团股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| US-20240115553-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS, INC. (US) | 2024-04-11 | — | — | US | claimed |
| US-20240009606-A1 | ELECTRETS COMPRISING A SUBSTITUTED CYCLOTRIPHOSPHAZENE COMPOUND AND ARTICLES THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2024-01-11 | — | — | US | claimed |
| CN-117043140-A | Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances | 拜耳公司 | 2023-11-10 | — | — | CN | claimed |
| WO-1995018617-A1 | 1-AMINOINDAN DERIVATIVES AND COMPOSITIONS THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 1995-07-13 | — | — | WO | claimed |
| WO-1995011016-A1 | R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDAN, SALTS, COMPOSITIONS AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 1995-04-27 | — | — | WO | claimed |
| EP-0436492-B1 | R-Enantiomer of N-propargyl-1-aminoindan, its preparation and pharmaceutical compositions containing it | TEVA PHARMA (IL) | 1994-06-08 | — | — | EP | claimed |
| EP-0578745-A1 | PHOSPHORUS CONTAINING COMPOUNDS AS INHIBITORS OF RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-01-19 | — | — | EP | claimed |
| CN-1073427-A | Phenyl ring list fluorizated N-propargyl-1-aminoidan reaches the selective depressant as monoamine oxidase (MAO) | TEVA PHARMA (IL) | 1993-06-23 | — | — | CN | claimed |
| EP-0538134-A2 | Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1993-04-21 | — | — | EP | claimed |
| WO-1992017490-A1 | PHOSPHORUS CONTAINING COMPOUNDS AS INHIBITORS OF RETROVIRUSES | THE UPJOHN COMPANY (US) | 1992-10-15 | — | — | WO | claimed |
| CN-1062900-A | The R-enantiomorph of N-propargyl-1-aminoidan, its method for making and contain its pharmaceutical composition | ORVET BV (NL) | 1992-07-22 | — | — | CN | claimed |
| EP-0436492-A2 | R-Enantiomer of N-propargyl-1-aminoindan, its preparation and pharmaceutical compositions containing it | Teva Pharmaceutical Industries Limited (IL) | 1991-07-10 | — | — | EP | claimed |
| EP-0144235-A2 | N6-(1- and 2-benzocycloalkyl) adenosines, pharmaceutical compositions comprising the same and a process for the production thereof | WARNER-LAMBERT COMPANY (US) | 1985-06-12 | — | — | EP | claimed |